Table 1

Recoveries of the radioactive doses after single 15-μmol/kg iv and po doses of [14C] I and po doses of the mono-, di-, and triester prodrugs to rats

I (Acid)I (Acid)II(Monoester)III (Diester)IV (Triester)
RouteIntravenousOralOralOralOral
Dose (μmol/kg)1515151515
Recovery (% of radioactive dose)
 JVC rats1-a
  Urine18.8  ± 1.02.2  ± 1.0
  Feces72.8  ± 1.296.5  ± 3.7
  Total91.7  ± 1.798.8  ± 2.7
 BDC rats1-b
  Bile41.3  ± 0.80.6  ± 0.13.2  ± 1.043.6  ± 7.229.0  ± 2.2
  Urine14.1  ± 0.70.5  ± 0.10.2  ± 0.033.4  ± 6.512.5  ± 1.0
  FecesNS1-c NSNSNS3.0  ± 2.6
  Liver31.3  ± 0.40.9  ± 0.32.6  ± 0.51.6  ± 0.52.4  ± 1.6
  Gastrointestinal tract0.7  ± 0.199.9  ± 0.787.4  ± 2.814.1  ± 0.948.1  ± 2.6
  Carcass7.7  ± 0.50.9  ± 0.85.2  ± 2.41-d 1.3  ± 0.71.0  ± 0.4
  Total95.1  ± 1.7102.8  ± 0.297.5  ± 1.094.0  ± 0.496.2  ± 0.5
Absorption (%)1-e 2.9  ± 0.56.0  ± 1.51-f 79.9  ± 1.245.2  ± 4.9
  • Values are mean ± SE (N = 3).

  • 1-a Study duration, 96 hr. JVC, jugular vein-cannulated.

  • 1-b Study duration, 12 hr.

  • 1-c NS, not significant.

  • 1-d The carcasses of two rats were contaminated by gastrointestinal tract contents. These values were excluded from the estimation of absorption.

  • 1-e Estimated as the sum of radioactivity recovered in all samples minus the radioactivity in feces and the gastrointestinal tract.

  • 1-f Estimated as the sum of radioactivity recovered in bile, urine, and liver.